Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501).
Higuchi K, Koizumi W, Tanabe S, Sasaki T, Katada C, Ishiyama H, Hayakawa K. Higuchi K, et al. Among authors: katada c. Radiother Oncol. 2008 Jun;87(3):398-404. doi: 10.1016/j.radonc.2008.03.006. Epub 2008 Apr 9. Radiother Oncol. 2008. PMID: 18405987 Clinical Trial.
Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
Higuchi K, Komori S, Tanabe S, Katada C, Azuma M, Ishiyama H, Sasaki T, Ishido K, Katada N, Hayakawa K, Koizumi W; Kitasato Digestive Disease and Oncology Group. Higuchi K, et al. Among authors: katada c, katada n. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):872-9. doi: 10.1016/j.ijrobp.2014.03.030. Epub 2014 May 24. Int J Radiat Oncol Biol Phys. 2014. PMID: 24867539 Clinical Trial.
Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical Esophagus.
Zenda S, Kojima T, Kato K, Izumi S, Ozawa T, Kiyota N, Katada C, Tsushima T, Ito Y, Akimoto T, Hasegawa Y, Kanamaru M, Daiko H. Zenda S, et al. Among authors: katada c. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):976-984. doi: 10.1016/j.ijrobp.2016.08.045. Epub 2016 Sep 3. Int J Radiat Oncol Biol Phys. 2016. PMID: 27745985 Free article. Clinical Trial.
Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence.
Yamashita K, Hosoda K, Moriya H, Katada C, Sugawara M, Mieno H, Komori S, Katada N, Watanabe M. Yamashita K, et al. Among authors: katada c, katada n. Oncology. 2017;92(4):221-228. doi: 10.1159/000455128. Epub 2017 Jan 21. Oncology. 2017. PMID: 28110330
Predisposing Factors for Chemotherapy-induced Nephrotoxicity in Patients with Advanced Esophageal Cancer Who Received Combination Chemotherapy with Docetaxel, Cisplatin, and 5-fluorouracil.
Mohri J, Katada C, Ueda M, Sugawara M, Yamashita K, Moriya H, Komori S, Hayakawa K, Koizumi W, Atsuda K. Mohri J, et al. Among authors: katada c. J Transl Int Med. 2018 Mar 28;6(1):32-37. doi: 10.2478/jtim-2018-0007. eCollection 2018 Mar. J Transl Int Med. 2018. PMID: 29607302 Free PMC article.
131 results